Broadfin Capital

Latest statistics and disclosures from Broadfin Capital's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are Horizon Pharma, FLML, PGNX, Aegerion Pharmaceuticals, EBS. These five stock positions account for 33.83% of Broadfin Capital's total stock portfolio.
  • Reduced shares in these 3 stocks: Eleven Biotherapeutics (-$90.45M), Ignyta (-$8.14M), INFI.
  • As of Dec. 31, 2014, Broadfin Capital has $1.15B in assets under management (AUM). Assets under management grew from a total value of $1.15B to $1.15B.
  • Independent of market fluctuations, Broadfin Capital was a net seller by $99.83M worth of stocks in the most recent quarter.

Broadfin Capital portfolio companies for December 2014 quarter

Ticker Name Portfolio Weight Change Share Count Price Last Trade
Horizon Pharma 10.33 9217975 12.89 0.00
FLML Flamel Technologies S.A. 7.68 5153190 17.13 15.72
PGNX Progenics Pharmaceuticals 6.02 9151169 7.56 6.57
Aegerion Pharmaceuticals 4.91 2698863 20.94 0.00
EBS Emergent BioSolutions 4.89 2066719 27.23 30.10
ANGO AngioDynamics 4.41 2670703 19.01 18.89
VOLC Volcano Corporation 3.88 2494854 17.88 17.99
Retrophin 2.83 2658854 12.24 0.00
BDSI BioDelivery Sciences International 2.50 2396399 12.02 15.32
PTX Pernix Therapeutics Holdings 2.49 3050000 9.39 10.70
Heron Therapeutics 2.46 2808173 10.06 0.00
DEPO DepoMed 2.40 1713702 16.11 23.06
Amphastar Pharmaceuticals 2.15 2127854 11.61 0.00
AMAG AMAG Pharmaceuticals 2.13 573530 42.62 49.70
Aratana Therapeutics 1.95 1259471 17.82 0.00
La Jolla Pharmaceuticl Com Par 1.80 1121370 18.45 0.00
KND Kindred Healthcare 1.76 1110300 18.18 21.81
RIGL Rigel Pharmaceuticals 1.68 8501750 2.27 3.06
DSCI Derma Sciences 1.50 1856877 9.31 7.96
ATRC AtriCure 1.43 825902 19.96 17.76
THOR Thoratec Corporation 1.41 500000 32.46 40.05
Anacor Pharmaceuticals In 1.41 504320 32.25 0.00
Universal American 1.40 1735553 9.28 0.00
IDRA Idera Pharmaceuticals 1.35 3525700 4.41 4.74
Dynavax Technologies 1.12 766010 16.86 0.00
AIS Antares Pharma 1.05 4700000 2.57 0.00
SLXP Salix Pharmaceuticals 1.00 100000 114.94 156.75
Eleven Biotherapeutics 1.00 -88.00% 108900 105.45 0.00
CNMD CONMED Corporation 0.98 250000 44.96 51.36
Ligand Pharmaceuticals In 0.92 199000 53.21 0.00
Corium Intl 0.92 1736736 6.10 0.00
Syneron Medical Ltd ord shs 0.82 1005221 9.33 0.00
DSCOD Discovery Laboratories 0.81 8066000 1.16 0.00
IG IGI Laboratories 0.75 974810 8.80 10.98
Zogenix 0.74 6237645 1.37 0.00
Xencor 0.73 520881 16.04 0.00
Trevena 0.73 1409153 5.98 0.00
Flexion Therapeutics 0.73 413204 20.19 0.00
Paratek Pharmaceuticals 0.70 260283 30.84 0.00
INFI Infinity Pharmaceuticals 0.66 -14.00% 386612 19.66 15.82
Tenax Therapeutics 0.66 1968631 3.84 0.00
CPRX Catalyst Pharmaceutical Partners 0.62 2400000 2.97 3.76
Cempra 0.58 284625 23.51 0.00
CRDC Cardica 0.54 8874992 0.70 0.63
Alliqua 0.54 1170910 5.30 0.00
Biota Pharmaceuticals 0.51 2611711 2.24 0.00
Dipexium Pharmaceuticals 0.47 475000 11.39 0.00
ARAY Accuray Incorporated 0.46 700000 7.55 8.81
Auspex Pharmaceuticals 0.46 100000 52.48 0.00
Novadaq Technologies 0.45 311403 16.62 0.00
Medgenics 0.45 1025000 5.06 0.00
Qlt 0.40 1145527 4.01 0.00
Iradimed 0.40 360884 12.90 0.00
Ignyta 0.38 -64.00% 225000 19.54 0.00
Adma Biologics 0.38 389193 11.17 0.00
Aquinox Pharmaceuticals 0.35 531768 7.50 0.00
Recro Pharma 0.35 1413533 2.86 0.00
ONTY Oncothyreon 0.33 2000000 1.90 1.64
AFAM Almost Family 0.32 128841 28.95 37.28
HTWR HeartWare International 0.32 50000 73.44 84.31
DRRX DURECT Corporation 0.30 4404495 0.79 1.03
Mirati Therapeutics 0.30 184756 18.52 0.00
Redhill Biopharma Ltd cmn 0.29 251509 13.33 0.00
CASM CAS Medical Systems 0.28 1918296 1.65 1.29
Anthera Pharmaceutcls 0.25 1783812 1.58 0.00
Tonix Pharmaceuticls 0.25 501639 5.84 0.00
MASI Masimo Corporation 0.22 97900 26.34 30.11
Celsus Therapeutics Plc sponsored adr ne 0.20 470877 4.80 0.00
AMRN Amarin Corporation 0.19 2233746 0.98 1.54
Rxi Pharmaceuticals 0.16 1126482 1.60 0.00
Biodel 0.15 1330034 1.33 0.00
RPTP Raptor Pharmaceutical 0.01 15558 10.54 9.90

Past 13F-HR SEC Filings for Broadfin Capital

View All Filings for Broadfin Capital